Dr Debra Barker appointed interim CEO of Destiny Pharma as Neil Clark steps down
BRIGHTON, UNITED KINGDOM: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today announces, ahead of the AGM, that Neil Clark has decided to step down…